Best Healthcare Companies in South Holland, Netherlands
The 75 best Healthcare companies in South Holland, Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Batavia Biosciences.
Ranked: Best Healthcare companies in South Holland
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 4MedBox Provider of personalized genetic locker for citizens to securely store and manage their biometric data… | — | — | Unfunded | — | Rick Overkleeft Co-Founder & CEO | — | — | — |
| 2 | Addoptics Provider of prototyping custom optics | — | — | Funding Raised | 17 | — | SanityNode.jsReact+12 | 13 patents Precision manufacturing of optical element moulds for lenses and optical components | — |
| 3 | Albert Schweitzer ziekenhuis Chain of multi speciality hospitals | — | — | Unfunded | — | Peter van der Meer CEO | VimeoNginxCloudflare+9 | — | — |
| 4 | Alrijne Health systems | — | — | Unfunded | 64 | — | Google MapsMicrosoft ASP.NETAzure Front Door+17 | — | — |
| 5 | Antec Scientific Provider of analytical instruments for high-performance liquid chromatography and mass spectrometry | — | — | Unfunded | — | Jean-Pierre Chervet CEO & President | WordPressMySQLPHP+25 | — | — |
| 6 | AudioNova Hearing aid retailer and service provider | — | — | Acquired | — | Frank Van Der Vis CEO | Cart FunctionalityMagentoMySQL+30 | — | — |
| 7 | Babysits Online and mobile-based platform for babysitters | — | — | Unfunded | 929 | Peter Soldt Founder | BootstrapGoogle WorkspaceGoogle Analytics+2 | — | — |
| 8 | BiosanaPharma Provider of product and formulation development services | — | — | Funding Raised | 22 | — | PimcorePHPNginx+5 | 4 patents Continuous biopharmaceutical production with real‑time process traceability | — |
Top 12 Healthcare companies in South Holland
#1
Series A · Rotterdam, South Holland · founded 2022 · 5 employees$5.9Mraised▾
Manufacturer of medical devices for laparoscopic surgeries
- Sep 2024Series A$5.5M
- Dec 2023Seed—
- Mar 2023Seed$379K
#2
Acquired · Leiden, South Holland · founded 2010 · 11 employees$40.4Mraised▾
Batavia Biosciences is a CDMO engaged in the development of biopharmaceutical products such as proteins, antibodies, vaccines and viral vectors. They have a portfolio of technologies for improving product yield (STEP®), to reduce process development time (SIDUS®, SCOUT®) and for improving product stability. Their STEP technology is a plasmid based expression platform that enables rapid mammalian CHO cell line generation and improved protein expression. Batavia claims that the STEP platform can offer up to 10-fold increase in protein expression and the stable cell clones can be generated in 14 weeks. They also have a transient production technology that can be used for producing clinical material (proteins) faster. The company claims to have expertise in upstream (mammalian, microbial and insect based platforms) and downstream processing, clinical and commercial manufacturing and also in DNA cloning and mammalian cell line generation.
- May 2023Grant (prize money)$444.3K
- Sep 2019Grant (prize money)$6.5M
- Jul 2019Grant (prize money)$2.2M
- Feb 2019Grant (prize money)$13.2M
#3
Series B · Leiden, South Holland · founded 2008 · 18 employees$11.1Mraised▾
Manufacturer of electrospun nanofiber-based medical devices
#4
Series A · Rotterdam, South Holland · founded 2018$5.7Mraised▾
Manufacturer of biosensors
- May 2023Series A$5.7M
- Jul 2022Seed—
- Nov 2019Grant (prize money)$55K
#5
Acquired · Leiden, South Holland · founded 1995$28.3Mraised▾
Company specializing in formulation and process development of complex injectables
#6
Seed · Leiden, South Holland · founded 2021 · 4 employees$396.2Kraised▾
Developer of biological analysis technology for the analysis of novel biomarkers exosomes intending to make diagnostics more specific. The company develops to provide methods for clinical research in therapeutics and diagnostics based on its patented microfluidic technology, enabling researchers to analyze extracellular vesicles, including exosomes that send messages to other cells.
- Apr 2023Grant (prize money)$204K
- Jun 2022Grant (prize money)$79.8K
- Feb 2022Seed$396.2K
#7
Acquired · Leiden, South Holland · founded 2011 · 31 employees$774.6Kraised▾
OcellO is a CRO that provides 3D screening services for drug discovery. It has a proprietary high throughput system for 3D imaging and phenotypic profiling that enables better quantification of complex biological phenomena combined with clinically relevant endpoints. Based on this platform, the company offers several drug screening and discovery services, including development of target-specific and immuno-oncology assays for screening drugs, phenotypic screening in disease models of interest and compound profiling, as well as a specialized drug candidate testing platform for polycystic kidney disease. In addition, OcellO offers in vitro 3D cell culture assays of patient-derived xenograft (PDX) mouse models for lead optimization, in partnership with Charles River Laboratories.
- Jan 2021Grant (prize money)$325.7K
- Feb 2018Grant (prize money)$289.2K
- Sep 2017Grant (prize money)$159.7K
#8
Funding Raised · Leiden, South Holland · founded 2017 · 12 employees$399.6Kraised▾
Developer of molecules and protein degraders for drug absorption. SeraNovo is a pharmaceutical formulation development company specialising in improving oral bioavailability for small molecules and protein degraders. Using our proprietary NanoGlass™ technologies, we design advanced formulations that enhance solubility, stability, and absorption for compounds with significant developability challenges. At the heart of the NanoGlass™ formulation technology approach lies a simple but powerful principle: to maximize oral bioavailability, the most effective strategy is to generate amorphous nanoparticles of the active pharmaceutical ingredient (API). We support drug developers from early preclinical stages through to clinical development by providing rapid feasibility studies, prototype development, and scalable formulation solutions.
- Apr 2020Grant (prize money)$60.5K
- Feb 2019Conventional Debt$339.1K
#9
Seed · Leiden, South Holland · founded 2017 · 11 employees$368.2Kraised▾
Provider of solutions for physiological-based cord clamping. It offers a method for delaying umbilical cord clamping until the baby is stable and breathing independently. This approach aims to minimize risks associated with early clamping, allowing the baby to receive maximum oxygen-rich blood from the placenta. The company provides products and educational resources to support healthcare professionals in implementing this technique, promoting improved neonatal outcomes and enhanced parent-newborn bonding. The company also conducts webinars to share scientific insights and practical experience related to this method.
- Feb 2018Seed$368.2K
#10
Funding Raised · Delft, South Holland · founded 2010$175.2Kraised▾
Manufacturer of medical and surgical equipment
- Nov 2017Grant (prize money)$91.7K
- Jan 2017Grant (prize money)$83.5K
#11
Funding Raised · The Hague, South Holland · founded 2016 · 8 employees$55.3Kraised▾
Operator of a medical company intended to develop medical devices and technology to keep people with Parkinson's disease active. The company's portable device can be worn invisibly under clothes and helps break freeze or gait on its own and provides support when needed, enabling healthcare providers to help people with Parkinson's to lead an active life for as long as possible.
- Dec 2019Grant (prize money)$55.3K
#12
Funding Raised · Delft, South Holland · founded 2018$22.8Kraised▾
Develops adjustable precision applicator
- Jun 2019Grant (prize money)$22.8K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.